Poor CYP2D6 and ultrarapid CYP2C19 metabolizer: Clinical challenge in psychiatric treatment

被引：0
|
作者：
Dlugauskas, E. [1 ]
Lengvenyte, A. [2 ]
Strumila, R. [3 ]
Utkus, A. [4 ]
机构：
[1] Vilnius Univ, Psychiat Clin, Ctr Neurol, Dept Psychiat, Vilnius, Lithuania
[2] Vilnius Univ, Fac Med, Psychiat Clin, Vilnius, Lithuania
[3] Vilnius Univ, Fac Med, Vilnius, Lithuania
[4] Vilnius Univ, Dept Human & Med Genet, Ctr Med Genet, Vilnius, Lithuania
来源：
EUROPEAN PSYCHIATRY | 2017年 / 41卷
关键词：
D O I：
10.1016/j.eurpsy.2017.01.2042
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EW0173
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [1] CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort
    Ivanov, Hristo Y.
    Grigorova, Denitsa
    Lauschke, Volker M.
    Velinov, Branimir
    Stoychev, Kaloyan
    Kyosovska, Gergana
    Shopov, Peter
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (07):
  • [2] Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer
    Brown, Jacob T.
    Schneiderhan, Mark
    Eum, Seenae
    Bishop, Jeffrey R.
    PHARMACOGENOMICS, 2017, 18 (07) : 601 - 605
  • [3] Genetic polymorphism of CYP2D6 and CYP2C19 in a large French psychiatric population and clinical implication in extreme metabolizer patients
    Dupouey, J.
    Quaranta, S.
    Faget-Agius, C.
    Richieri, R.
    Laaroussi, A.
    Saut, N.
    Berge-Lefranc, J. L.
    Guilhaumou, R.
    Micallef, J.
    Lancon, C.
    Blin, O.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 61 - 61
  • [4] The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19
    de Leon, Jose
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (03) : 241 - 245
  • [5] Genotypes for the cytochrome P450 enzymes CYP2D6 and CYP2C19 in human longevity Role of CYP2D6 and CYP2C19 in longevityRole of CYP2D6 and CYP2C19 in longevity
    L. Bathum
    K. Andersen-Ranberg
    J. Boldsen
    K. Brøsen
    B. Jeune
    European Journal of Clinical Pharmacology, 1998, 54 : 427 - 430
  • [6] Methodology for clinical genotyping of CYP2D6 and CYP2C19
    Henriques, Beatriz Carvalho
    Buchner, Avery
    Hu, Xiuying
    Wang, Yabing
    Yavorskyy, Vasyl
    Wallace, Keanna
    Dong, Rachael
    Martens, Kristina
    Carr, Michael S.
    Asl, Bahareh Behroozi
    Hague, Joshua
    Sivapalan, Sudhakar
    Maier, Wolfgang
    Dernovsek, Mojca Z.
    Henigsberg, Neven
    Hauser, Joanna
    Souery, Daniel
    Cattaneo, Annamaria
    Mors, Ole
    Rietschel, Marcella
    Pfeffer, Gerald
    Hume, Stacey
    Aitchison, Katherine J.
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [7] Methodology for clinical genotyping of CYP2D6 and CYP2C19
    Beatriz Carvalho Henriques
    Avery Buchner
    Xiuying Hu
    Yabing Wang
    Vasyl Yavorskyy
    Keanna Wallace
    Rachael Dong
    Kristina Martens
    Michael S. Carr
    Bahareh Behroozi Asl
    Joshua Hague
    Sudhakar Sivapalan
    Wolfgang Maier
    Mojca Z. Dernovsek
    Neven Henigsberg
    Joanna Hauser
    Daniel Souery
    Annamaria Cattaneo
    Ole Mors
    Marcella Rietschel
    Gerald Pfeffer
    Stacey Hume
    Katherine J. Aitchison
    Translational Psychiatry, 11
  • [8] Quantification of Antidepressant and Antipsychotic Exposure Increase Caused by CYP2C19 and CYP2D6 Intermediate and Poor Metabolizer Status
    Milosavljevic, Filip
    Bukvic, Nikola
    Pesic, Vesna
    Pavlovic, Zorana
    Miljevic, Cedo
    Molden, Espen
    Ingelman-Sundberg, Magnus
    Jukic, Marin
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 139 - 139
  • [9] Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19
    Beatriz Carvalho Henriques
    Avery Buchner
    Xiuying Hu
    Yabing Wang
    Vasyl Yavorskyy
    Keanna Wallace
    Rachael Dong
    Kristina Martens
    Michael S. Carr
    Bahareh Behroozi Asl
    Joshua Hague
    Sudhakar Sivapalan
    Wolfgang Maier
    Mojca Z. Dernovsek
    Neven Henigsberg
    Joanna Hauser
    Daniel Souery
    Annamaria Cattaneo
    Ole Mors
    Marcella Rietschel
    Gerald Pfeffer
    Stacey Hume
    Katherine J. Aitchison
    Translational Psychiatry, 12
  • [10] Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin
    Ibeanu, GC
    Goldstein, JA
    Meyer, U
    Benhamou, S
    Bouchardy, C
    Dayer, P
    Ghanayem, BI
    Blaisdell, J
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (03): : 1490 - 1495
12345